Personal information

breast cancer, oncology

Activities

Employment (1)

Kyoto Prefectural University of Medicine: Kyoto, 465 Kawaramachi-hirokoji,Kamigyo-ku, Kyoto, , JP

2010-04-01 to present (Department of Surgery, Division of Endocrine & Breast Surgery)
Employment
Source: Self-asserted source
MIDORI MORITA

Works (9)

Validation of late recurrence prediction by gene expression profiles and clinicopathological factors in estrogen receptor-positive breast cancer

Breast Cancer
2024-09 | Journal article
Contributors: Sae Kitano; Ryo Tsunashima; Chikage Kato; Akira Watanabe; Yoshiaki Sota; Saya Matsumoto; Midori Morita; Koichi Sakaguchi; Yasuto Naoi
Source: check_circle
Crossref

Investigation of recurrence prediction ability of EndoPredict® using microarray data from fresh frozen tissues in ER-positive, HER2-negative breast cancer and indication expansion of EndoPredict® from microarray data from fresh-frozen to FFPE tissues

Breast Cancer
2024-07 | Journal article
Contributors: Akira Watanabe; Ryo Tsunashima; Chikage Kato; Sae Kitano; Saya Matsumoto; Yoshiaki Sota; Midori Morita; Koichi Sakaguchi; Yasuto Naoi
Source: check_circle
Crossref

Seven‐plus hours of daily sedentary time and the subsequent risk of breast cancer: Japan Multi‐Institutional Collaborative Cohort Study

Cancer Science
2024-02 | Journal article
Contributors: Satomi Tomida; Teruhide Koyama; Etsuko Ozaki; Naoyuki Takashima; Midori Morita; Koichi Sakaguchi; Yasuto Naoi; Yuichiro Nishida; Megumi Hara; Asahi Hishida et al.
Source: check_circle
Crossref

Detection of high-risk patients resistant to CDK4/6 inhibitors with hormone receptor-positive HER2-negative advanced and metastatic breast cancer in Japan (KBCSG-TR-1316)

Breast Cancer
2023-11 | Journal article
Contributors: Manabu Futamura; Takahiro Nakayama; Tetsuhiro Yoshinami; Chiya Oshiro; Mikiya Ishihara; Midori Morita; Akira Watanabe; Azusa Tanigichi; Masami Tsukabe; Masafumi Shimoda et al.
Source: check_circle
Crossref

Optimal Treatment of Hormone Receptor-positive Advanced Breast Cancer Patients With Palbociclib.

Anticancer research
2023-06-01 | Journal article
Contributors: Morita M; Ooe A; Ishii W; Watanabe A; Matsui C; Okuyama Y; Kitano S; Kato C; Onishi M; Sakaguchi K et al.
Source: Self-asserted source
MIDORI MORITA

Multi-gene assay 95- and 155-gene classifiers for prognosis prediction and chemotherapy omission in lymphnode positive luminal-type breast cancer.

Cancer treatment and research communications
2023-05-18 | Journal article
Contributors: Matsumoto S; Tsunashima R; Kitano S; Watanabe A; Kato C; Morita M; Sakaguchi K; Győrffy B; Naoi Y
Source: Self-asserted source
MIDORI MORITA

Is adjuvant chemotherapy necessary in older patients with breast cancer?

Breast cancer (Tokyo, Japan)
2022-01-15 | Journal article
Contributors: Morita M; Akihiko Shimomura; Tokuda E; Horimoto Y; Kawamura Y; Ishizuka Y; Sekine K; Obayashi S; Kojima Y; Uemura Y et al.
Source: Self-asserted source
MIDORI MORITA

Plasmalogen Deficiency and Overactive Fatty Acid Elongation Biomarkers in Serum of Breast Cancer Patients Pre- and Post-Surgery—New Insights on Diagnosis, Risk Assessment, and Disease Mechanisms

Cancers
2021-08 | Journal article | Author
Contributors: Satomi Tomida; Dayan B. Goodenowe; Teruhide Koyama; Etsuko Ozaki; Nagato Kuriyama; MIDORI MORITA; Yasuyo Yamazaki; Koichi Sakaguchi; Ritei Uehara; tetsuya taguchi
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Fluorescence‐based discrimination of breast cancer cells by direct exposure to 5‐aminolevulinic acid

Cancer Medicine
2019-09 | Journal article
Contributors: Midori Morita; Hideo Tanaka; Yasuaki Kumamoto; Akihiro Nakamura; Yoshinori Harada; Takehiro Ogata; Koichi Sakaguchi; Tetsuya Taguchi; Tetsuro Takamatsu
Source: check_circle
Crossref